Advertise on podcast: CM Conversations

This episode of CM Conversations speaks with Dr. Callie Seaman, a formulation chemist with over 20 years experience in the hydroponics industry. Through her own struggle with epilepsy, she has become a leading advocate and educator for medicinal and prescription cannabis in the UK. Alongside her important work campaigning in this field, she is a Director at Aqualabs and MedCan Support. In this episode Business Consultant Joe Holmes, a specialist recruiter in the medical cannabis market, discusses with her the challenges, likelihood, and potential benefits of legalisation in the UK and what this really means for the industry. Whether you’re in the cannabis industry or not, this episode has some invaluable insight for anyone interested in new and emerging markets in the Life Science sector. If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn.

In this episode of CM Conversations mini-series, Lessons from Leaders in Life Science, CM Life Science Business Consultant, Jack Maclean, speaks with Grant Neckermann, SVP of Talent at Syapse. Syapse is an innovator in the oncology space, changing the way data is used to help leading doctors and researchers make better decisions and accelerate the future of medicine. In this episode, we talk all things talent. From the passion Grant had for his own progression, to leading an innovative start-up through the challenges of ensuring impactful growth through investment in people. Whether you’re interested in learning valuable insight from a leader in Life Science, great tips for talent management, or just want to hear an inspiring story – then be sure to have a listen! If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn.

In this episode of CM Conversations mini-series, Lessons from Leaders in Life Science, CM Life Science Business Consultant, Jack Maclean, speaks with Jen Skeen, Chief Operating Officer at Renegade.bio. Moving from a scientific background to the forefront of an innovative leadership team at a disruptive company like Renegade.bio is no mean feat. Jen delves into the trials and tribulations of her climb to the top as a woman in science, discussing how to find your niche and build a career based on what you like. Whether you’re interested in learning valuable insight from a leader in Life Sciences, great tips for networking in the space, or want to hear an inspiring story – then be sure to have a listen! If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself, or want to learn more about CM Life Science's services; then please drop me a message at [email protected] or let's connect on LinkedIn.

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, Nathan Sharpe speaks with Wendy Harman, Vice President of Product and Commercial at Weavr Health. After being selected as one of the Built In Boston 'Best Small Companies To Work For', and announcing its recent Labcorp partnership, we discuss the successes and challenges of retaining a core company culture when scaling a fast-growing start-up. From how to build a company culture that attracts the best talent, to what makes their innovative approaches and technologies different to others in the market, Wendy shares plenty of insight you won't want to miss. Whether you’re in the diagnostics industry or not, this episode has some invaluable info for those looking to change an industry's approach to company culture. If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then drop Nathan a message at [email protected].

In this episode, I talk to Avi Fischer, CEO of innovative Italian medtech start-up, Electrophysiology Frontiers. He discussed the excitement and challenges of heading up a start-up creating a unique catheter ablation product, the first of its kind in the market. We discuss the future of cardiac ablation procedures and the innovative devices under development which are set to change the landscape of how we treat A-fib. Whether you're in the device or wider Cardiovascular market, Avi's insight as an ex-physician and successful industry leader is not one to miss! If you'd like to get in touch to discuss any points featured in this episode, would like to be a future podcast guest or want to learn more about our CM Medical services; then please email me at [email protected].

In the final part of this three-part episode, Dennis and Adam discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine. Dennis touches on how to become a legendary company in your market, and what this means in liquid biopsy terms. A truly eye-opening discussion which anyone would be sure to gain something from. In parts one and two, we discussed the importance of liquid biopsy for the future oncology market as well as strategies for overcoming barriers when entering new markets. A huge thanks to Dennis for coming on to share his knowledge and experience. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at [email protected].

In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe. This conversation comes in three parts. In part one, the pair discussed the importance of liquid biopsy for the future oncology market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at [email protected].

In the second episode of Diagnostics Digest, Adam speaks to Dennis Merkle, CEO of Europe and Global Head of Biopharma Business for molecular insights company, Predicine. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Here we jump into a well-rounded discussion on the benefits of liquid biopsy in today's oncology market. This conversation comes in three parts. In part two, we delve into crucial barriers within the market. Part three discusses new liquid biopsy technologies and what's new at Predicine. Be sure to subscribe to be notified when all parts are available. If you'd like to get in touch about this episode, be a future podcast guest, or learn more about CM Life Science's services, please email Adam at [email protected].

In this episode we speak with Sandeep Sandhu, General Manager of the Americas at RPM Global, about the power of digitisation to help traditional mining practices meet sustainable goals. In this discussion, our Associate Director at CM Industrial and specialist recruiter in the global Mining space, Jamie Sheard, discusses the the importance of software and cloud-based technologies as mining solutions, and the role digitisation plays in reaching sustainable goals. RPM Global is an Australian based company, whose recent expansion and success across the Americas is largely attributed to these strategies. Whether you’re in the mining technology industry, are interested in ways to adapt business models to meet new sustainability initiatives or are interested in learning about expansion into new territories, there’s something in here for everyone. Enjoy! Please get in touch with Jamie at [email protected], if you'd like to discuss the topic and trend in some more detail.

In this episode I talk to Bassel Rifai, SVP and Chief Marketing Officer at Ambu A/S, a company whose single-use endoscopes are some of the most innovative currently available on the market. Despite potential questions as to its sustainability, the result of COVID makes these products more crucial than ever. Bassel touches on these alongside many other interesting topics, including key learnings, challenges and successes Ambu has embraced as a result of a changing market. A hugely engaging personality with some brilliant insight into the market. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Medical services; then please email me at [email protected].

This is the first in a new CM Life Science series discussing trends and insights into the diagnostics market with industry leaders from across the globe. In this episode, I talk with Delphine Galezowski, Director of Market Development in Europe for Adaptive Biotechnologies.  We discuss European market expansion strategies within the diagnostics space, the differences between European market access and other global territories, and insights from her time leading teams at AstraZeneca. Whether you’re in the diagnostics industry, are intrigued by market access strategies, or are wondering how different organisations and regions differ within the market – then be sure to have a listen. In the following episodes my colleagues will be discussing a range of key trends and insights into key topics within the wider diagnostics market, too. So please subscribe to the series to be notified when their episodes become available. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Life Science's services; then please email me at [email protected].

In this episode I speak with Laura Bishop, Director of Infinitas Design and Chair of the GSHPA. As a specialist recruiter in the Rotating Equipment Space, I was keen to discuss the noticeable lack of talent in the booming heat pump market with someone as insightful as Laura. As governments continue to implement extreme sustainability goals, is the market set to grow at an unmanageable rate? We discuss this, and much more, as she pulls on her wealth of industry experience from leading sustainable design teams at EON to launching her own commercial and industrial renewable heat systems company in October 2020. Whether you’re in the heat pump market, are intrigued by discussions around the future impact of government mandates and new technologies or are wondering what their introduction means for your company and market – then be sure to have a listen. If you'd like to get in touch about this episode, would like to be a future podcast guest or want to learn more about CM Industrial's services; then please email me at [email protected].